Previous 10 | Next 10 |
Edison Nation (NASDAQ: EDNT ) +169% on over $10M order . More news on: Edison Nation, Inc., Soligenix, Inc., Atossa Therapeutics, Inc., Stocks on the move, , Read more ...
HOUSTON , April 16, 2020 /PRNewswire/ -- Moleculin Biotech, Inc., (Nasdaq: MBRX) ("Moleculin" or the "Company"), a clinical stage pharmaceutical company with a broad portfolio of drug candidates, announced that Walter Klemp , Chairman and Chief Executive Officer, will host a web-bas...
HOUSTON , April 15, 2020 /PRNewswire/ -- Moleculin Biotech, Inc., (Nasdaq: MBRX) ("Moleculin" or the "Company"), a clinical stage pharmaceutical company with a broad portfolio of drug candidates, today announced that Dr. Dominique Schols of the Rega Institute has joined the Molecul...
Sonnet BioTherapeutics Holdings (NASDAQ: SONN ) +100% . More news on: Sonnet BioTherapeutics Holdings, Inc., MEI Pharma, Inc., NantKwest, Inc., Stocks on the move, Read more ...
HOUSTON , April 14, 2020 /PRNewswire/ -- Moleculin Biotech, Inc., (Nasdaq: MBRX) ("Moleculin" or the "Company"), a clinical stage pharmaceutical company with a broad portfolio of drug candidates, today announced that Walter Klemp , Chairman and Chief Executive Officer, will host a w...
AMC Entertainment Holdings (NYSE: AMC ) -17% on potential Chapter 11 filing . More news on: AMC Entertainment Holdings, Inc., Enzo Biochem, Inc., CleanSpark, Inc., Stocks on the move, , Read more ...
Thinly traded nano cap CNS Pharmaceuticals (NASDAQ: CNSP ) jumps 19% premarket on light volume on the heels of its announced collaboration with WPD Pharmaceuticals to develop several preclinical COVID-19 candidates, including WP112, that WPD in-licensed from Moleculin Biotech (...
VANCOUVER, British Columbia, April 09, 2020 (GLOBE NEWSWIRE) -- WPD Pharmaceuticals Inc. (CSE: WBIO)(FSE: 8SV1) (the “Company” or “WPD” ) a clinical stage pharmaceutical company , is pleased to announce that independent research on its WP1122 drug compound ...
Gainers: Moleculin Biotech (NASDAQ: MBRX ) +121% . More news on: Moleculin Biotech, Inc., Ellington Financial Inc., Intelsat S.A., Stocks on the move, , Read more ...
April 8, 2020 Palm Beach, FL – April 8, 2020 – The search for vaccines and treatments for the global health crises is now focusing on medicines that are presently approved for other ailments. A recent article in the LA Times discussed this issue saying that when ...
News, Short Squeeze, Breakout and More Instantly...
Moleculin Biotech Inc. Company Name:
MBRX Stock Symbol:
NASDAQ Market:
Moleculin Biotech Inc. Website:
Moleculin Completes End of Phase 2 Meeting with FDA for Annamycin in AML PR Newswire HOUSTON , July 10, 2024 /PRNewswire/ -- Moleculin Biotech, Inc. , (Nasdaq: MBRX) ("Moleculin" or the "Company"), a clinical stage pharmaceutical company with a broad portfoli...
2024-06-17 10:10:00 ET June 17, 2024 (Investorideas.com Newswire) Investorideas.com , a go-to investing platform releases the first of a two-part series looking at developments for the treatment of blood cancers. Today's snapshot focuses in on acute myeloid leukemia (AML) and the compan...
Moleculin Announces Additional Positive Preliminary Interim Data from AML Clinical Trial PR Newswire – 89% of CRc's were subjects with "poor prognosis" cytogenetics and/or mutations – Current median durability of response (mDOR) of CRc's = 6 months and in...